Sudarshan Pharma Industries has received approval to relocate its greenfield projects from Maharashtra to Gujarat due to local resistance. The company also secured an extension to their project deadline. Both the Vitamin B6 and Vitamin B1 projects must now be commercially operational by December 31, 2027. The company recently acquired a manufacturing facility in Telangana for ₹25.50 crore.